EcoDrugPlus

Amine Oxidase Copper Containing 3

Ensembl ID : ENSVVUG00000023933
Gene Symbol: AOC3
3 Cross references
316 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSVVUG00000024221
Gene Symbol: APP
3 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSVVUG00000017276
Gene Symbol: AR
3 Cross references
277 Possible Orthologues:

Angiotensin I Converting Enzyme

Ensembl ID : ENSVVUG00000005728
Gene Symbol: ACE
4 Cross references
93 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSVVUG00000012243
Gene Symbol: AGTR1
3 Cross references
207 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSVVUG00000018586
Gene Symbol: AGTR2
3 Cross references
191 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSVVUG00000017314
Gene Symbol: APLNR
3 Cross references
171 Possible Orthologues:

Aph-1 Homolog A, Gamma-Secretase Subunit

Ensembl ID : ENSVVUG00000007850
Gene Symbol: APH1A
3 Cross references
137 Possible Orthologues:

Aph-1 Homolog B, Gamma-Secretase Subunit

Ensembl ID : ENSVVUG00000011390
Gene Symbol: APH1B
3 Cross references
190 Possible Orthologues:

Apurinic/apyrimidinic Endodeoxyribonuclease 1

Ensembl ID : ENSVVUG00000009010
Gene Symbol: APEX1
3 Cross references
212 Possible Orthologues:

Arachidonate 12-Lipoxygenase, 12s Type

Ensembl ID : ENSVVUG00000027589
Gene Symbol: ALOX12
4 Cross references
200 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSVVUG00000021199
Gene Symbol: ALOX5
3 Cross references
220 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).